0001209191-14-075844.txt : 20141216
0001209191-14-075844.hdr.sgml : 20141216
20141216161151
ACCESSION NUMBER: 0001209191-14-075844
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141212
FILED AS OF DATE: 20141216
DATE AS OF CHANGE: 20141216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH IAN F
CENTRAL INDEX KEY: 0001197032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 141289765
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-12-12
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197032
SMITH IAN F
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP & CFO
Common Stock
2014-12-12
4
S
0
3162
119.82
D
116706
D
Common Stock
2014-12-12
4
S
0
2880
120.44
D
113826
D
Common Stock
5306
I
401(k)
Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $119.82 (range $119.21 to $120.20).
Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $120.44 (range $120.22 to $120.84).
Kenneth L. Horton, Attorney-In-Fact
2014-12-16